首页> Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation> Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies.

Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies.

导出原文传递

翻译打印收藏纠错

第一作者： Ying,Wang

第一单位： Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Key Laboratory of Bone Marrow Stem Cell, Jiangsu Province, Xuzhou, China.

作者： Ying,Wang ^[1] ; Kunming,Qi ^[1] ; Hai,Cheng ^[1] ; Jiang,Cao ^[1] ; Ming,Shi ^[2] ; Jianlin,Qiao ^[3] ; Zhiling,Yan ^[1] ; Guangjun,Jing ^[4] ; Bin,Pan ^[3] ; Wei,Sang ^[1] ; Depeng,Li ^[1] ; Xiangmin,Wang ^[1] ; Chunling,Fu ^[3] ; Feng,Zhu ^[1] ; Junnian,Zheng ^[5] ; Zhenyu,Li ^[6] ; Kailin,Xu ^[7]

作者单位： Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Key Laboratory of Bone Marrow Stem Cell, Jiangsu Province, Xuzhou, China. ^[1] Cancer Institute, Xuzhou Medical University, Xuzhou, China; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China; Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. ^[2] Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Key Laboratory of Bone Marrow Stem Cell, Jiangsu Province, Xuzhou, China. ^[3] iCARTAB Biomedical Co. LTD, Suzhou, China. ^[4] Cancer Institute, Xuzhou Medical University, Xuzhou, China; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China; Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. Electronic address: jnzheng@xzmc.edu.cn. ^[5] Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Key Laboratory of Bone Marrow Stem Cell, Jiangsu Province, Xuzhou, China. Electronic address: lizhenyumd@163.com. ^[6] Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Key Laboratory of Bone Marrow Stem Cell, Jiangsu Province, Xuzhou, China. Electronic address: lihmd@163.com. ^[7]

关键词 Adverse events CAR-T cell therapy CRS Coagulation disorders DIC

医学主题词血液凝固障碍(Blood Coagulation Disorders);血液肿瘤(Hematologic Neoplasms);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive)

DOI 10.1016/j.bbmt.2019.11.027

PMID 31786240

发布时间 2022-05-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交